Inside Innovation

Magnolia Medical, a Seattle-based biotech company, raised $46 million to further propel product innovation. This financing follows a record-setting new account acquisition and top-line sales

Cuervo Vaccine, a Seattle-based company, recently secured $60 million in a Series A financing round. The company, which works to develop safe and highly effective

Cell therapy company Juno Therapeutics was sold to Celgene in 2018, but its impact still reverberates throughout Seattle’s life science industry today. The company’s successes

Bristol Myers Squibb announced its newest round of funding as part of its 2020 pledge to donate $150 million over the next five years to

Vancouver, Washington is experiencing a biotech boom, fueled by companies like Absci, CytoDyn and Capsigen who are leading the way in developing new technologies to

As the search for what causes long-COVID continues, researchers at Seattle’s Institute for Systems Biology may have found some answers as to what factors cause